Skip to main content
Genome Announcements logoLink to Genome Announcements
. 2016 Dec 8;4(6):e01081-16. doi: 10.1128/genomeA.01081-16

Draft Genome Sequences of Three Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Isolates from Bacteremia

Chaitra Shankar a, Laura E B Nabarro a, Naveen Kumar Devanga Ragupathi a, Dhiviya Prabaa Muthuirulandi Sethuvel a, Jones Lionel Kumar Daniel a, George Priya Doss C b, Balaji Veeraraghavan a,
PMCID: PMC5146430  PMID: 27932638

Abstract

Hypervirulent Klebsiella pneumoniae strains have been increasingly reported worldwide, and there is emergence of carbapenem resistance among them. Here, we report the genome sequences of three carbapenem-resistant hypervirulent K. pneumoniae isolates isolated from bacteremic patients at a tertiary-care center in South India.

GENOME ANNOUNCEMENT

Klebsiella pneumoniae is a common pathogen causing both community-acquired and hospital-acquired infections (1). Carbapenems are the drug of choice for treating extended-spectrum β-lactamase (ESBL)-producing K. pneumoniae infections. However, carbapenem resistance is now commonly seen due to increased usage and leads to a high mortality rate of 30% to 44% (24). Hence, tigecycline and colistin are current therapeutic choices.

Hypervirulent K. pneumoniae, first identified from cases of liver abscess, has been increasingly reported worldwide. K. pneumoniae strains have characteristic hypermucoviscous colonies on culture medium, identified phenotypically by a positive string test. They are associated with several virulence factors compared to the classical strains, which include rmpA, rmpA2, magA, siderophores, such as aerobactin, enterobactin, and yersiniabactin, and genes coding for allantoin metabolism.

Three string test-positive carbapenem-resistant K. pneumoniae isolates (B1647, B20038, and B20143) from blood culture were identified. All three isolates were from health care-acquired infections, and two of the three patients died. The meropenem MICs for the isolates were >16 µg/ml, as determined by Etest (bioMérieux). DNA for the isolates were extracted using QIAsymphony, as per the manufacturer’s instructions. Whole-genome sequencing was performed by next-generation sequencing using IonTorrent and assembled using SPAdes version 5.0. The contigs were annotated using RAST (http://rast.nmpdr.org/) and Patric (http://patricbrc.org/). The MLST, ResFinder, and PlasmidFinder (http://www.genomicepidemiology.org/) databases were used to find the sequence type, antibiotic resistance genes, and the plasmid types present in the isolates. Virulence genes were defined with the help of database available at http://bigsdb.pasteur.fr/perl/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef_public&page=downloadAlleles.

The isolates were found to harbor the rmpA2 gene, which is characteristically associated with hypervirulent strains. The isolates belonged to three different sequence types (STs), namely, ST11, ST43, and ST231, indicating that they are from different lineages. The isolates do not belong to the K1 serotype, as they lacked the magA gene. The isolates harbored IncFIA, IncFIB, IncFII, IncHI1B, and Col types of plasmids. Since the isolates were multidrug resistant, they were found to harbor several genes coding for antimicrobial resistance against aminoglycosides, quinolones, beta-lactams, fosfomycin, and rifampin. aac(6′)lb-cr, coding for both fluoroquinolones and aminoglycosides, was also found. B1647 and B20143 showed the presence of genes coding for phenicol and sulfonamide resistance. All three isolates harbored blaOXA genes (blaOXA-232, blaOXA-181, and blaOXA-1), while the third isolate, B20143, had both the blaNDM-1 and blaOXA-1 genes. Among the genes encoding carbapenem resistance, blaNDM and blaOXA genes are commonly seen in India (5, 6). The isolates encoded genes for siderophores, such as iutA, iucA, iucB, and iucD for aerobactin; entA, entD, entE, and entF for enterobactin, and ybtA, ybtU, ybtT, irp1, irp2, and fyuA for yersiniabactin. Siderophores, one of the important virulence factors, have varied affinities for iron, with aerobactin having the lowest affinity and enterobactin having the highest (7, 8). B1647 and B20143 isolates carried the mrkD gene encoding type 3 fimbriae, which aids biofilm formation (9). All carried the virulence factor MviM and genes coding for iron acquisition, such as kfuA, kfuB, and kfuC.

Accession number(s).

The whole-genome sequences of the three carbapenem-resistant hypervirulent K. pneumoniae (CR-hvKp) isolates have been deposited at GenBank under the accession numbers MCFO00000000 (B1647), MCFP00000000 (B20038), and MCFQ00000000 (B20143).

ACKNOWLEDGMENT

This work was funded by Fluid Research Grant, Christian Medical College, Vellore, Tamil Nadu, India.

Footnotes

Citation Shankar C, Nabarro LEB, Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Daniel JLK, Doss C GP, Veeraraghavan B. 2016. Draft genome sequences of three hypervirulent carbapenem-resistant Klebsiella pneumoniae isolates from bacteremia. Genome Announc 4(6):e01081-16. doi:10.1128/genomeA.01081-16.

REFERENCES

  • 1.Podschun R, Ullmann U. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11:589–603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:1028–1033. doi: 10.1128/AAC.01020-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:1099–1106. doi: 10.1086/592412. [DOI] [PubMed] [Google Scholar]
  • 4.Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. 2007. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study. J Antimicrob Chemother 60:1124–1130. doi: 10.1093/jac/dkm356. [DOI] [PubMed] [Google Scholar]
  • 5.Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R. 2010. New Delhi metallo-beta lactamase-1 (NDM-1) in Enterobacteriaceace: treatment options with carbapenems compromised. J Assoc Physicians India 58:147–149. [PubMed] [Google Scholar]
  • 6.Bhaskar MM, Anand R, Harish BN. 2013. Prevalence of blaNDM-producing blood isolates of Escherichia coli, Klebsiella species and Enterobacter species in a tertiary care centre in South India. J Microbiol Res Rev 16:61–68. [Google Scholar]
  • 7.Brock JH, Williams PH, Licéaga J, Wooldridge KG. 1991. Relative availability of transferrin-bound iron and cell-derived iron to aerobactin- producing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infect Immun 59:3185–3190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Perry RD, Balbo PB, Jones HA, Fetherston JD, DeMoll E. 1999. Yersiniabactin from Yersinia pestis: biochemical characterization of the siderophore and its role in iron transport and regulation. Microbiology 145:1181–1190. doi: 10.1099/13500872-145-5-1181. [DOI] [PubMed] [Google Scholar]
  • 9.Schroll C, Barken KB, Krogfelt KA, Struve C. 2010. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol 10:179. doi: 10.1186/1471-2180-10-179. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES